AquAgro Fund I

Desalitech, Inc. designs and manufactures advanced industrial reverse osmosis systems for water purification and desalination. The company's flagship product, ReFlex, is versatile and suitable for applications such as pure water supply, boiler feed water, cooling tower makeup, and wastewater reuse. Additionally, the ReFlex Max system addresses brine concentration and seawater desalination needs. Desalitech also offers ReFlex Smart, a software solution for online monitoring and control of its systems. Founded in 2008 by Professor Avi Efraty and originally named Advanced Desalination Technologies, the company focuses on providing efficient water treatment solutions that adapt to varying conditions, reducing operational challenges and costs. Desalitech serves a range of industries, including food and beverage, oil and gas refining, mining, consumer goods, municipal reuse, and power generation, both in the United States and internationally. As of early 2020, Desalitech operates as a subsidiary of DuPont de Nemours, Inc. and is based in Newton, Massachusetts.

EnzymoCore is a start-up company focused on developing biocatalyst substitutes for chemical catalysts used in the production of biodiesel fuels. Founded in 2007 and based in Shefa-'Amr, Israel, EnzymoCore's innovative enzymatic technologies are designed to enhance the production of biodiesel from a wide range of feedstocks, including both vegetable and animal-based oils, particularly those with high fatty acid content. By providing a more efficient and cost-effective solution for biodiesel production, the company aims to support the growing demand for renewable energy sources as alternatives to petroleum-based fuels.

Evogene Ltd. is a computational biology company headquartered in Rehovot, Israel, focused on the discovery and development of life-science products across various industries, including agriculture, human health, and industrial applications. Utilizing its Computational Predictive Biology (CPB) platform, Evogene combines deep biological insights with big data and artificial intelligence to enhance product development efficiency and efficacy. The Agriculture segment works on seed traits and ag-chemical products aimed at improving crop performance for species such as corn, soybean, and cotton. In the Human Health sector, the company develops microbiome-based therapeutics targeting immuno-oncology and gastrointestinal disorders, along with medical cannabis products. The Industrial Applications segment concentrates on enhancing castor bean seeds for biofuel production. Evogene operates globally, with a presence in the United States, Israel, and Brazil, and maintains strategic collaborations and licensing agreements with major agricultural firms. Founded in 1999, the company leverages advanced technologies to transform life-science product development processes.